Disclaimer: Compounded PT-141 (bremelanotide) is prepared by a licensed 503A compounding pharmacy and has not been reviewed or approved by the FDA. This article reflects my perspective as a founder and is for educational purposes only. It is not medical advice, does not establish a provider-patient relationship, and is not a self-dosing guide. PT-141 dosing must be determined and supervised by a licensed provider.
Search “PT-141 dosage” and you will find an ocean of dosage charts, calculators, and confident numbers, most of them published by vendors selling peptides for people to dose themselves. I want to take a different approach here, because the honest and responsible answer to “what dose should I take?” is not a number off a chart. It is: the dose your provider determines is right for you, based on factors a chart cannot know. Let me explain how physicians actually think about PT-141 dosing and why the personalized approach matters.
Why I Am Not Going to Hand You a Number
Let me be direct about why this article does not include a dosing chart. PT-141 affects blood pressure and heart rate, it produces dose-related side effects like nausea, and the appropriate amount depends on your individual health, your cardiovascular status, and how you respond.[1] A number pulled from a generic chart cannot account for any of that.
The vendors publishing dosage calculators are generally selling to people injecting peptides without medical oversight. That is a fundamentally different and riskier situation than what we do, which is physician-supervised therapy with a dose chosen for the individual. Handing out a universal number would be exactly the kind of thing this company exists to be an alternative to.
What a Physician Actually Considers
When our providers determine a PT-141 protocol, they weigh several things that a chart never sees:
Your cardiovascular health. This is first for a reason. Because PT-141 can transiently raise blood pressure and lower heart rate, your blood pressure and cardiovascular history directly shape whether it is appropriate at all and, if so, how conservatively to begin.[1]
Starting conservatively. Side effects, particularly nausea, tend to be dose-related. A careful provider generally starts at a lower dose to assess your individual tolerance rather than beginning aggressively. You can adjust upward with guidance; you cannot un-take a dose that was too much.
Your individual response. People differ in both benefit and side effects at a given dose. Part of good dosing is starting, observing how you actually respond, and refining from there, rather than assuming a one-size number is correct.
As-needed use. PT-141 is typically used on an as-needed basis, taken in advance of anticipated activity rather than on a daily schedule. How that fits your situation is part of the conversation.
Why Medical Supervision Genuinely Matters Here
I want to make the case for supervision plainly, because it is the entire difference between our model and the self-dosing world.
A provider evaluating you before prescribing PT-141 does several things a chart cannot: screens your cardiovascular health to determine whether it is safe for you at all, selects a starting point appropriate to your individual situation, guides any adjustment based on your actual response, and is available if something does not go as expected. The screening matters because the people for whom PT-141 is genuinely risky, those with uncontrolled hypertension or significant cardiovascular disease, are exactly the people a dosage chart will never identify or warn.[2]
This is not medical gatekeeping for its own sake. It is the reason a supervised approach is safer than the alternative for a medication with real cardiovascular considerations.
The Bottom Line
The right PT-141 dose is not a number you can look up; it is a clinical decision made with a provider who knows your health, screens your cardiovascular status, starts conservatively, and adjusts based on how you actually respond. The dosage charts and calculators filling search results are built for a self-dosing world that carries risks a personalized, supervised approach is designed to avoid. If you are considering PT-141, the right first step is an evaluation with a licensed provider, not a chart.
If you want a medically supervised approach to PT-141, that begins with a licensed provider who can review your health and determine what is appropriate for you. Learn more about our physician-supervised PT-141 program.
References
- Molinoff PB, Shadiack AM, Earle D, et al. PT-141: a melanocortin agonist for the treatment of sexual dysfunction. Ann N Y Acad Sci. 2003;994:96-102. PubMed: 12851303
- Kingsberg SA, Clayton AH, Portman D, et al. Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials. Obstet Gynecol. 2019;134(5):899-908. PubMed: 31599840
This article reflects my personal perspective as a founder and is for educational purposes only. It is not medical advice, does not establish a provider-patient relationship, and is not a self-dosing guide. Compounded medications have not been reviewed by the FDA and are not the same as commercially available FDA-approved products. Please consult a licensed provider.
JP Rius is the founder of Precision Telemed. His perspective is shaped by the commercial, regulatory, and operational side of telehealth medicine.